Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2025)

Camp4 Therapeutics' Cash from Investing Activities history spans 3 years, with the latest figure at $36000.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities changed N/A year-over-year to $36000.0; the TTM value through Dec 2025 reached -$243000.0, up 44.9%, while the annual FY2025 figure was -$243000.0, 44.9% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was $36000.0 at Camp4 Therapeutics, up from -$279000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $36000.0 in Q3 2025 and bottomed at -$279000.0 in Q1 2025.
  • The 3-year median for Cash from Investing Activities is -$203000.0 (2023), against an average of -$154500.0.
  • The largest annual shift saw Cash from Investing Activities dropped 8.23% in 2024 before it crashed 1760.0% in 2025.
  • A 3-year view of Cash from Investing Activities shows it stood at -$243000.0 in 2023, then decreased by 8.23% to -$263000.0 in 2024, then surged by 113.69% to $36000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Cash from Investing Activities are $36000.0 (Q3 2025), -$279000.0 (Q1 2025), and -$263000.0 (Q4 2024).